Wespac Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Wespac Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$883.2 - $1071.19 $82,137 - $99,620	-93 Reduced 29.52%	222 $233,000
Q1 2024 Apr 24, 2024	SELL	$902.69 - $993.35 $3,610 - $3,973	-4 Reduced 1.25%	315 $303,000
Q4 2023 Jan 25, 2024	SELL	$775.18 - $881.7 $12,402 - $14,107	-16 Reduced 4.78%	319 $280,000
Q3 2023 Oct 25, 2023	BUY	$692.45 - $844.37 $231,970 - $282,863	335 New	335 $275,000
Q1 2023 Apr 26, 2023	BUY	$680.49 - $826.97 $185,093 - $224,935	272 New	272 $223,000
Q3 2020 Oct 27, 2020	SELL	$544.75 - $658.21 $184,670 - $223,133	-339 Closed	0 $0
Q2 2020 Jul 22, 2020	BUY	$493.32 - $643.92 $167,235 - $218,288	339 New	339 $211,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Wespac Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Wespac Advisors, LLC with notifications on news.